Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership

  OSLO, Norway, December 19, 2022 / B3C newswire / -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that it has entered into a strategic manufacturing partnership with Richter-Helm BioLogi...

Related Keywords

Oslo ,Norway ,Germany ,Hamburg ,Mette Husbyn ,Kai Pohlmeyer ,Agnete Fredriksen ,Linkedin ,Genentech ,International Cooperation ,Roche Group ,Helm Biologics Gmbh Co ,Gedeon Richter Plc ,Oslo Stock Exchange ,Nykode Therapeutics ,Richter Helm Biologics Gmbh ,Chief Technology Officer ,Managing Director ,Richter Helm Biologics ,Antigen Presenting Cells ,Adaptive Biotechnologies ,Drug Substance ,Industrial Facilities ,Biological Products ,